MBC Pharma, Inc. With a focus on improving upon existing drugs, MBC Pharma's patented technologies offer tissue targeting and enhanced cancer cell specificity and uptake. Driven by their mission to create value through groundbreaking therapeutics, MBC Pharma utilizes their platform technologies to address significant challenges in oncological, bone, and infectious diseases.

Their research and development programs revolve around two core proprietary discovery platforms. The first platform involves bone-targeting using bone-homing bisphosphonates conjugated to either anticancer or anti-infective drug payloads. This platform has already demonstrated human proof of concept in a Phase I clinical trial, specifically targeting patients with established bone lesions caused by breast, prostate, or cervical cancer.

MBC Pharma's second platform focuses on Vitamin B6-based nucleotide pro-drugs, which show promise in the treatment of oncology and viral diseases. Located in Aurora, CO, MBC Pharma, Inc. Contact them today to learn more about their revolutionary developments